Total Payments
$4,729
2024 Payments
$1,246
Companies
37
Transactions
323
Medicare Patients
1,667
Medicare Billing
$117,356
Payment Breakdown by Category
Food & Beverage$4,660 (98.5%)
Education$68.99 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,660 | 322 | 98.5% |
| Education | $68.99 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $735.21 | 51 | $0 (2024) |
| ABBVIE INC. | $687.77 | 68 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $404.23 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $304.19 | 20 | $0 (2024) |
| Amgen Inc. | $235.90 | 14 | $0 (2024) |
| Lilly USA, LLC | $228.31 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $213.25 | 11 | $0 (2023) |
| Dexcom, Inc. | $211.97 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $203.63 | 13 | $0 (2024) |
| Amarin Pharma Inc. | $168.14 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,246 | 84 | Novo Nordisk Inc ($194.37) |
| 2023 | $1,152 | 77 | ABBVIE INC. ($209.03) |
| 2022 | $1,015 | 73 | Novo Nordisk Inc ($199.55) |
| 2021 | $1,316 | 89 | Novo Nordisk Inc ($204.03) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Biological | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $68.99 | General |
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 512 | 790 | $107,461 | $36,608 |
| 2022 | 8 | 359 | 552 | $80,900 | $29,193 |
| 2021 | 11 | 431 | 571 | $83,602 | $31,570 |
| 2020 | 10 | 365 | 501 | $67,344 | $19,985 |
Total Patients
1,667
Total Services
2,414
Medicare Billing
$117,356
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 220 | $46,473 | $13,169 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $15,389 | $7,099 | 46.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 39 | 94 | $9,588 | $3,707 | 38.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $8,606 | $3,658 | 42.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $4,070 | $1,582 | 38.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 24 | 50 | $7,150 | $1,483 | 20.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,608 | $1,450 | 40.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 36 | $4,032 | $1,103 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 86 | 121 | $1,397 | $1,001 | 71.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $805.00 | $665.39 | 82.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 18 | $2,070 | $540.36 | 26.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $455.00 | $376.09 | 82.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 25 | 25 | $1,100 | $267.26 | 24.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 33 | $1,584 | $258.97 | 16.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 21 | $924.00 | $199.92 | 21.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 21 | $210.00 | $46.20 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 226 | $47,234 | $14,291 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $16,575 | $7,884 | 47.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $9,930 | $3,910 | 39.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 20 | $2,850 | $1,364 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 21 | $735.00 | $578.41 | 78.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $630.00 | $498.46 | 79.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 92 | 150 | $1,650 | $445.02 | 27.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 27 | $1,296 | $223.15 | 17.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 226 | $47,234 | $16,052 | 34.0% |
About Amanda Evans, FNP
Amanda Evans, FNP is a Family healthcare provider based in Greer, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1154752780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Evans, FNP has received a total of $4,729 in payments from pharmaceutical and medical device companies, with $1,246 received in 2024. These payments were reported across 323 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,660).
As a Medicare-enrolled provider, Evans has provided services to 1,667 Medicare beneficiaries, totaling 2,414 services with total Medicare billing of $117,356. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Greer, SC
- Active Since 12/08/2013
- Last Updated 06/06/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1154752780
Products in Payments
- FARXIGA (Drug) $360.67
- Ozempic (Drug) $335.73
- UBRELVY (Drug) $260.67
- QULIPTA (Drug) $207.27
- JARDIANCE (Drug) $199.40
- Dexcom G6 Transmitter (Medical Supply) $196.06
- TRINTELLIX (Drug) $192.38
- Vascepa (Drug) $168.14
- VRAYLAR (Drug) $161.96
- ELIQUIS (Drug) $154.13
- TRADJENTA (Drug) $132.40
- Rybelsus (Drug) $131.03
- TRELEGY ELLIPTA (Drug) $130.44
- Tresiba (Drug) $130.43
- Aimovig (Biological) $126.68
- Cologuard Collection Kit (Device) $107.24
- MOUNJARO (Drug) $94.22
- LEQVIO (Drug) $88.60
- SOLIQUA 100/33 (Biological) $85.76
- XIFAXAN (Drug) $84.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Greer
Sarah Valerio, Crnp, CRNP
Family — Payments: $75,880
Family $75,880
Mrs. Porshia Miller, Fnp-C, FNP-C
Family — Payments: $7,947
Family $7,947
Ms. Amy Boone, Fnp, FNP
Family — Payments: $4,854
Family $4,854
Vladislav Abaturov, Np, NP
Family — Payments: $4,258
Family $4,258
Kacie Carter, Fnp, FNP
Family — Payments: $2,626
Family $2,626
Elizabeth Murray
Family — Payments: $2,537
Family $2,537